Menarini Korea starts marketing of PE drug Priligy

Published: 2013-04-05 06:58:00
Updated: 2013-04-05 06:58:00
Menarini Korea can now resell its premature ejaculation (PE) treatment Priligy (dapoxetine) here after winning the rights to commercialize Priligy last year.

The Korean unit of Menarini Group, an international pharmaceutical company, said it will reduce the price of Priligy by 30 percent.

P...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.